Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Amgen Inc.
IndexS&P 500 P/E21.11 EPS (ttm)6.16 Insider Own0.10% Shs Outstand757.02M Perf Week6.56%
Market Cap98.42B Forward P/E14.88 EPS next Y8.74 Insider Trans32.11% Shs Float756.23M Perf Month9.83%
Income4.72B PEG2.87 EPS next Q2.07 Inst Own82.80% Short Float1.11% Perf Quarter16.98%
Sales18.96B P/S5.19 EPS this Y20.30% Inst Trans0.27% Short Ratio2.89 Perf Half Y10.25%
Book/sh30.04 P/B4.33 EPS next Y8.01% ROA7.80% Target Price132.18 Perf Year19.17%
Cash/sh26.16 P/C4.97 EPS next 5Y7.36% ROE21.70% 52W Range101.35 - 128.26 Perf YTD15.18%
Dividend2.44 P/FCF23.69 EPS past 5Y12.00% ROI10.50% 52W High1.37% Beta0.53
Dividend %1.88% Quick Ratio3.10 Sales past 5Y4.50% Gross Margin80.50% 52W Low28.28% ATR2.41
Employees20000 Current Ratio3.50 Sales Q/Q6.70% Oper. Margin31.70% RSI (14)75.62 Volatility1.35% 1.62%
OptionableYes Debt/Eq1.41 EPS Q/Q-25.50% Profit Margin24.90% Rel Volume2.91 Prev Close123.31
ShortableYes LT Debt/Eq1.30 EarningsJul 29 AMC Payout32.30% Avg Volume2.90M Price130.01
Recom2.30 SMA208.20% SMA5010.07% SMA20011.42% Volume8,433,338 Change5.43%
30-Jul-14Reiterated RBC Capital Mkts Outperform $125 → $138
18-Jul-14Reiterated Deutsche Bank Buy $144 → $149
23-Apr-14Reiterated Oppenheimer Perform $121 → $122
21-Mar-14Reiterated Barclays Equal Weight $115 → $130
31-Jan-14Reiterated Argus Buy $130 → $135
20-Nov-13Reiterated Deutsche Bank Buy $138 → $142
29-Aug-13Reiterated UBS Buy $121 → $124
27-Aug-13Reiterated Barclays Overweight $105 → $115
31-Jul-13Reiterated Oppenheimer Perform $100 → $109
24-Apr-13Reiterated Deutsche Bank Buy $108 → $115
15-Apr-13Reiterated Barclays Equal Weight $90 → $105
08-Apr-13Reiterated RBC Capital Mkts Outperform $95 → $105
25-Jan-13Upgrade Argus Hold → Buy $96
24-Jan-13Reiterated UBS Buy $96 → $98
12-Sep-12Downgrade Robert W. Baird Outperform → Neutral $84
10-Sep-12Upgrade UBS Neutral → Buy $80 → $96
02-Aug-12Downgrade Argus Buy → Hold
15-Mar-12Resumed Stifel Nicolaus Hold
09-Feb-12Downgrade Oppenheimer Outperform → Perform
09-Sep-11Downgrade Standpoint Research Buy → Hold
30-Jul-14 06:00PM  [video] Cramer's 5 steps of the stock market at CNBC +5.43%
05:34PM  Small biopharma companies see large gains on a big earnings day at MarketWatch
05:02PM  AMGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
04:42PM  [$$] Amgen Makes the Cut at Barrons.com
02:18PM  Today's Trades: 3 Big Stocks Getting Big Attention at TheStreet
01:42PM  Amgen Price Target Raised by Various Analysts Benzinga
01:21PM  Rising sales and job cut plan boost Amgen at Financial Times
01:08PM  Amgen, Regeneron rise as health-care companies see strong earnings at MarketWatch
11:45AM  Amgen's stock soars to record high on news of planned job cuts at Los Angeles Times
11:20AM  Amgen Restructuring Plan, Q2 Earnings Send Stock Up at Investor's Business Daily
11:05AM  Amgen Pleases the Street -- but Will Layoffs Keep Critics at Bay? at TheStreet
10:50AM  Major markets little changed after economic news AP
10:50AM  Amgen shares hit record on cost-cutting plans at MarketWatch
10:20AM  [video] Stocks Rise at the Open as U.S. Economy Grows Above Estimates at TheStreet
09:59AM  Amgen Surges on News It Will Cut 2,400 Jobs at Bloomberg
09:50AM  [video] The Top Ten Stocks for Wednesday, July 30 at Bloomberg
09:48AM  Cramer: These 2 biotech stocks are going higher at CNBC
09:45AM  Trade-Ideas: Amgen (AMGN) Is Today's New Lifetime High Stock at TheStreet
09:21AM  Morning Roundup: Earnings Better Than Expected at Barrons.com
09:15AM  [video] Cramer: AmEx great blue chip stock at CNBC
09:10AM  DreamWorks dives; SodaStream pops; Twitter soars Hot Stock Minute
09:02AM  Will This Price Target Increase Help Amgen (AMGN) Stock Today? at TheStreet
09:00AM  Amgen Reports Stellar Earnings, Raises Guidance Benzinga
08:20AM  Amgen Beats on Q2 Earnings & Revs, Ups View & Plans Job Cuts Zacks
07:56AM  McDonald's labor ruling; Twitter shares soar; 2Q GDP Hot Stock Minute
06:02AM  U.S. Stock-Index Futures Gain Before Fed as Twitter Jumps at Bloomberg
12:51AM  [$$] Amgen Plans to Cut Up To 15% of Workers at The Wall Street Journal
29-Jul-14 11:08PM  Amgen to cut 2,900 workers and close four facilities at Los Angeles Times
10:59PM  [$$] Amgen Plans to Cut Up To 15% of Workers at The Wall Street Journal
08:54PM  [$$] Amgen Plans to Cut Up To 15% of Workers at The Wall Street Journal
07:56PM  [$$] Amgen Plans Job Cuts at The Wall Street Journal
07:35PM  Amgen Plans Job Cuts and Plant Closings at New York Times
07:35PM  Amgen Plans Job Cuts and Plant Closings at New York Times
07:17PM  Biotech drugmaker Amgen laying off at least 2,400 AP
07:14PM  [$$] Amgen Plans Job Cuts at The Wall Street Journal
07:03PM  [$$] Amgen Plans Job Cuts at The Wall Street Journal
06:54PM  Twitter Rallying With Amgen Takes Bite Out of Fed Warning at Bloomberg
06:03PM  What recovery? Amgen axing up to 2,900 jobs at CNNMoney.com
05:41PM  Amgen to lay off up to 2,900 workers and close plants in two states at Los Angeles Times
05:13PM  Amgen to cut at least 2,400 jobs, close plants at Los Angeles Times
05:00PM  Amgen Inc Earnings Call scheduled for 5:00 pm ET today CCBN
04:47PM  Biotech drugmaker Amgen laying off at least 2,400 AP
04:42PM  Why Amgen (AMGN) Stock Is Up in After-Hours Trading Today at TheStreet
04:41PM  [$$] Amgen Plans Job Cuts at The Wall Street Journal
04:37PM  Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 PR Newswire
04:28PM  Amgen to cut at least 2,400 jobs, close plants at Los Angeles Times
04:21PM  Indexes End Lower As Russia Sanctions Hit Stocks at Investor's Business Daily
04:18PM  Amgen 2nd quarter profit rises; announces up to 2,900 job cuts Reuters
04:16PM  [video] Earnings roundup: AXP, PNRA & BWLD at CNBC
04:14PM  Amgen Says It Will Cut More Than 2,400 Jobs Worldwide at Bloomberg
04:12PM  AMGEN INC Files SEC form 8-K, Results of Operations and Financial Condition, Costs Associated with Exit or Disposal A EDGAR Online
04:07PM  Biotech drugmaker Amgen laying off at least 2,400 AP
09:04AM  Stock Futures Show Some Muscle; Merck, Cognex Rising at Investor's Business Daily
07:34AM  Amgen Inc Earnings Call scheduled for 5:00 pm ET today CCBN
07:07AM  Q2 2014 Amgen Earnings Release - After Market Close CCBN
28-Jul-14 06:49PM  Top 5 Earnings Reports To Watch After The Close Tue. at Investor's Business Daily
04:36PM  Why the Fed could start raising rates sooner than you think at CNBC
02:52PM  What to Watch in The Day Ahead; Tuesday, July 29 Reuters
12:06PM  Amgen Shares Have the Right Prescription for Long-Term Growth at TheStreet
08:55AM  5 Huge Biotech Catalysts Right Around the Corner for Top Stocks at 24/7 Wall St.
25-Jul-14 06:10PM  Traders brace for summer's busiest week at CNBC
04:00PM  Amgen Announces 2014 Third Quarter Dividend PR Newswire
01:45PM  Bayer/Amgen's Nexavar Does Not Show Resilience in Study Zacks
10:52AM  ROTH Capital's Debjit Chattopadhyay: Marriage Of Diagnostics To New Therapies Breeds Biotech Winners at Seeking Alpha
07:36AM  EMA adopts positive opinion on new indication for Xgeva theflyonthewall.com
02:30AM  Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR® (sorafenib) in Patients with Advanced Breast Cancer PR Newswire
24-Jul-14 04:00PM  Amgen Announces Webcast of 2014 Second Quarter Financial Results PR Newswire
01:21AM  IPO Preview: Atara Biotherapeutics at Seeking Alpha
23-Jul-14 01:35PM  [video] Power Countdown: Biotech, social & Internet at CNBC
10:54AM  Biogen Idec: Biggest Beat in 10 Years, Largest Leap in Eight Months at Barrons.com
08:56AM  Do You Have The Best or Worst 401(k) Plan? at Forbes
22-Jul-14 05:04PM  Why Investors Continue to Flee Aegerion Stock at Motley Fool
02:44PM  3 Stocks Reiterated As A Buy: CAT, BIIB, AMGN at TheStreet
02:22PM  Amgen Can Propel Over $120 With Earnings Right Around The Corner at Seeking Alpha
11:10AM  [video] Which Company Offers the Best 401(k) Plan? at Bloomberg
06:13AM  [$$] 9 Health Care Stocks From Index-Crushing Fund at Barrons.com
21-Jul-14 03:11PM  Astellas Up on Pipeline Update, Oncology in Focus (revised) Zacks
01:15PM  Amgen's AMG 416 Succeeds in Phase III, Shares Up Zacks
18-Jul-14 03:40PM  Biotech Enters Reporting Season With Large Caps Central To Sector Performance Benzinga
07:26AM  Amgen: Grappling With The Reality Of Patent Expiries at Seeking Alpha
17-Jul-14 05:52PM  Amgen parathyroid drug found effective in kidney patient trial Reuters
05:32PM  [$$] Amgen Hormone Drug Proves Positive in Study at The Wall Street Journal
04:29PM  Amgen thyroid drug succeeds in late stage kidney patient trial Reuters
04:01PM  Amgen Announces Positive Phase 3 Results for AMG 416 for the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease Receiving Hemodialysis PR Newswire
16-Jul-14 02:50PM  Astellas Up on Pipeline Update, Oncology in Focus Zacks
10:15AM  4 Top Biotechs Expected to Beat Earnings Expectations at 24/7 Wall St.
15-Jul-14 02:24PM  Q2 2014 Update: My Whistler Income And Growth Portfolio at Seeking Alpha
11:21AM  Amgen (AMGN) Roof Leaking Today at TheStreet
10:33AM  Facebook, Twitter slip following cautious valuation comments from Fed at theflyonthewall.com
14-Jul-14 01:14PM  3 Stocks Reiterated As A Buy: AXP, BIDU, AMGN at TheStreet
10-Jul-14 08:20AM  The Zacks Analyst Blog Highlights: Regado Biosciences, Jazz Pharmaceuticals, Regeneron Pharmaceuticals, Sanofi and Amgen Zacks
09-Jul-14 11:52AM  Celgene Drug Otezla Fails Trial, But Street Sanguine at Investor's Business Daily
08-Jul-14 02:42PM  Alexion Pharma Looks To Life Beyond Its Blockbuster at Investor's Business Daily
10:03AM  Gilead Sciences: How Big a Beat? at Barrons.com
08:54AM  Story Stocks from Briefing.com Briefing.com
08:39AM  Story Stocks from Briefing.com Briefing.com
07-Jul-14 10:28AM  Story Stocks from Briefing.com Briefing.com
09:48AM  Story Stocks from Briefing.com Briefing.com
09:17AM  Story Stocks from Briefing.com Briefing.com
08:46AM  Story Stocks from Briefing.com Briefing.com
Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine worldwide. Its principal products include Neulasta, a pegylated protein for the treatment of chemotherapy-induced febrile neutropenia; NEUPOGEN, a recombinant-methionyl human granulocyte colony-stimulating factor for treating the patients with non-myeloid malignancies; and Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis in adult patients. The company's principal products also comprise Aranesp and EPOGEN erythropoiesis-stimulating agents for the treatment of anemia and dialysis; XGEVA and Prolia for the prevention of skeletal-related events and treatment of postmenopausal women with osteoporosis; and Sensipar/Mimpara products for use in the treatment of secondary hyperparathyroidism in CKD patients on dialysis. Its other marketed products include Nplate, a thrombopoietic compound; and Vectibix, a human monoclonal antibody. The company's products in phase 3 clinical trial comprise Evolocumab, a human monoclonal antibody used for the treatment for dyslipidemia; Talimogene Laherparepvec for the treatment of unresected stage IIIB, IIIC, or IV melanoma; and Trebananib for the treatment of ovarian cancer. Its other product in development stage includes Ivabradine, an oral drug for chronic heart failure and stable angina in patients with elevated heart rates. The company markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and pharmaceutical wholesale distributors. It has collaborative arrangements with Pfizer Inc.; Glaxo Group Limited; AstraZeneca Plc.; Takeda Pharmaceutical Company Limited; UCB; and Bayer HealthCare Pharmaceuticals Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dittrich Thomas J.W.VP, Finance & CAOMay 21Option Exercise56.644,130233,91122,719May 22 05:15 PM
Dittrich Thomas J.W.VP, Finance & CAOMay 21Sale112.834,130465,98418,589May 22 05:15 PM
Bradway Robert AChairman, CEO and PresidentMay 12Buy111.7789499,919185,013May 12 08:33 PM
Michael A KellyActing CFOApr 28Sale110.452,065228,07241,041Apr 29 05:48 PM
de Carbonnel FrancoisDirectorMar 06Option Exercise54.4410,000544,35025,364Mar 07 05:23 PM
de Carbonnel FrancoisDirectorMar 06Sale126.691,000126,69018,343Mar 07 05:23 PM
BALTIMORE DAVIDDirectorFeb 26Option Exercise62.555,000312,75031,879Feb 26 08:28 PM
HENDERSON REBECCA MDirectorFeb 13Option Exercise62.4120,0001,248,16025,549Feb 14 04:34 PM
HENDERSON REBECCA MDirectorFeb 13Sale123.5320,0002,470,6805,549Feb 14 04:34 PM
Bradway Robert AChairman, CEO and PresidentFeb 12Option Exercise62.5565,0004,065,750216,040Feb 14 04:19 PM
AMGEN INC10% OwnerDec 17Buy7.00272,1421,904,994541,399Dec 18 06:09 PM
Balachandran MadhavanEVP, OperationsSep 04Option Exercise58.4318,0001,051,74059,133Sep 05 07:33 PM
Balachandran MadhavanEVP, OperationsSep 04Sale112.7618,0002,029,76834,851Sep 05 07:33 PM
BALTIMORE DAVIDDirectorAug 28Sale109.664,582502,46227,789Aug 30 05:36 PM